The maker’s program

CGM Pharmacy Copay Program

Savings card from MiniMed (Medtronic Diabetes)

With commercial insurance · as little as $60 for a month of sensors

Commercial insurance with pharmacy coverage for the sensor only; the program pays at most $380 a month and $2,000 a year. Not for Medicare, Medicaid, VA or TRICARE, and not in Massachusetts or Michigan.

See it on minimed.com 

In the maker’s words

“Pay as little as $60 for a one-month supply of sensors”

From the maker’s page on minimed.com, checked November 17, 2026.

From MiniMed (Medtronic Diabetes)’s own website, in its own words. DrugAlt reads each page again every week.

More ways to pay less

What it is

A small sensor worn on the skin that reads glucose (sugar) around the clock and sends the readings to a connected device.

Used for: Tracking glucose (sugar) levels in diabetes; Spotting episodes of high and low glucose (sugar); Sending glucose readings to connected devices, including systems that adjust insulin automatically.

In the FDA’s records’ words

Percutaneous interstitial fluid glucose monitoring system, electrochemical. An assembly of electrically-powered, portable devices intended to continuously monitor interstitial fluid glucose concentrations in a patient with diabetes mellitus, using an invasive electrochemical technique. It consists of an electrochemical, percutaneously-inserted electrode that physically connects to a cable or transmitter which communicates with a monitor or receiver (not included) that captures, stores, and converts the sensor signals to glucose concentrations for display. The system may be used in the home and clinical settings, and aids in the detection of episodes of hyperglycaemia and hypoglycaemia, facilitating acute/long-term therapy adjustments.

Integrated Continuous Glucose Monitoring system, factory calibrated. An integrated continuous glucose monitoring system (iCGM) is intended to automatically measure glucose in bodily fluids continuously or frequently for a specified period of time. iCGM systems are designed to reliably and securely transmit glucose measurement data to digitally connected devices, including automated insulin dosing systems, and are intended to be used alone or in conjunction with these digitally connected medical devices for the purpose of managing a disease or condition related to glycemic control.

Only your prescriber can say whether a device is right for you.

In the FDA’s device database

1 version sold now

Each opens its FDA record. The model number is on the box.

Source: the FDA’s device database (GUDID), November 2, 2026.

Similar devices

All 9 continuous glucose monitors